{"id":502156,"date":"2020-08-13T17:46:01","date_gmt":"2020-08-13T17:46:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=502156"},"modified":"2020-08-13T17:46:01","modified_gmt":"2020-08-13T17:46:01","slug":"covid19-impact-on-meningococcal-vaccines-market-2020-indepth-analysis-top-company-share-and-regional-statistics-industry-size-share-growth","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/covid19-impact-on-meningococcal-vaccines-market-2020-indepth-analysis-top-company-share-and-regional-statistics-industry-size-share-growth_502156.html","title":{"rendered":"Covid-19 Impact on Meningococcal Vaccines Market 2020, In-Depth Analysis, Top Company Share and Regional Statistics, Industry Size, Share, Growth"},"content":{"rendered":"
\"Covid-19<\/a><\/p>\n
\n
Meningococcal Vaccines Market<\/div>\n<\/div>\n<\/div>\n
Global Meningococcal Vaccines Market Research Report: Information, by Treatment (Meningococcal Conjugate Vaccine, Polysaccharide & Subcapsular Vaccine) and End User (Hospitals & Clinics, Research Laboratories and Academic Institutes) – Forecast till 2025<\/div>\n

Meningococcal Vaccines Market <\/strong>Highlights<\/strong><\/p>\n

According to Market Research Future (MRFR) analysis, the Meningococcal Vaccines Market 2020 can thrive at a considerable CAGR across the analysis period 2019 to 2025. By 2025, the meningococcal vaccine market can touch USD Million from USD 172 Million in 2019.<\/p>\n

The rise in cases of meningococcal disease is expected to support the expansion of the market through the analysis period. As the mortality rate of meningococcal disease surge, the demand for vaccine increases. A high number of people have shown resistance to the disorder on vaccination. Thus, the increase in cases of prevention of meningococcal disorder by vaccination have created high demand. The rise in the production for meningococcal vaccine is observed to meet its rising need. These factors are expected to drive the market across the analysis period. In addition, hefty investment and increase in research and development for the identification and formulation of novel drug moiety to prevent meningococcal vaccine market can bolster the rise of the market through the review period. However, issues regarding approval of research projects can limit the growth of the meningococcal vaccine market in the years ahead. <\/p>\n

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https:\/\/www.marketresearchfuture.com\/sample_request\/8622<\/a><\/strong><\/p>\n

Meningococcal Vaccines Market <\/strong>Segmentation<\/strong><\/p>\n

The segment assessment of the Meningococcal Vaccines global Market is done by treatment type and end-user.<\/p>\n

The treatment type based segments of the meningococcal market are polysaccharide, sub-capsular vaccine, and meningococcal conjugate vaccine. The polysaccharide segment can surge due to the increase in demand for products, such as MenACWY vaccines. In addition, the rise in demand for novel MenB vaccines can support the expansion of the meningococcal vaccine market across the analysis period.<\/p>\n

The end-user based segments of the meningococcal vaccines global market are research & academic institutes, and hospitals & clinics among others. The hospitals and clinics segment is expected to significantly control the meningococcal vaccines market in the years to come. The expansion of the hospitals and clinics segment can be attributed to the rise in the application of vaccines and easy accessibility to healthcare facilities. The rise in number of in-patients suffering from meningococcal disease can contribute to the expansion of the segment, which, in turn, impact the market rise. The increase in R&D for the investigation of new drug to treat meningococcal problem can cause the research laboratories and academic segment to surge in the years to come. <\/p>\n

Meningococcal Vaccines Market <\/strong>Regional Analysis<\/strong><\/p>\n

The application of meningococcal vaccines for the immunization of special risk groups, such as travellers and military personnel are highly recommended, although not-reimbursed. The launch of immunization program in meningitis prone countries include meningococcal vaccines only for risk groups. The increased in such cases and active steps taken by healthcare welfare controlling governments and organizations are forces that are likely to contribute to the expansion of the meningococcal vaccines market in the Asia Pacific region. The rise in interest for the introduction of multivalent and conjugate vaccine into scheduled national immunization programs in the MEA region can contribute to the regional market expansion. In North America, the easy availability of expertise can contribute to the expansion of the regional market. The ease of availability of C- and W-containing vaccines as issues related to these sero-groups are increasing can support the expansion of meningococcal vaccines market<\/a> <\/strong>across the analysis period. Europe meningococcal vaccine market can surge due to the increase in cases of medical cases in the region. <\/p>\n

Meningococcal Vaccines Market <\/strong>Key Players<\/strong><\/p>\n

Baxter International, Novartis Pharmaceuticals Canada Inc, Pfizer Inc., Sanofi S.A., Biomed Pvt. Ltd., JN-International Medical Corporation, GlaxoSmithKline, and Serum Institute of India Ltd. among others are some influential meningococcal vaccines markets as listed by MRFR.<\/p>\n

Table Of Contents
<\/strong><\/p>\n

1. EXECUTIVE SUMMARY
<\/strong><\/p>\n

1.1. Market Attractiveness Analysis<\/p>\n

1.1.1. Global Meningococcal Vaccines Market, By Treatment Type<\/p>\n

1.1.2. Global Meningococcal Vaccines Market, By End User<\/p>\n

2. MARKET INTRODUCTION
<\/strong><\/p>\n

2.1. Definition<\/p>\n

2.2. Scope Of The Study<\/p>\n

2.2.1. Research Objective<\/p>\n

2.2.2. Assumptions<\/p>\n

2.2.3. Limitations<\/p>\n

3. RESEARCH METHODOLOGY
<\/strong><\/p>\n

3.1. Overview<\/p>\n

3.2. Data Mining<\/p>\n

3.3. Secondary Research<\/p>\n

3.4. Primary Research<\/p>\n

3.5. Breakdown Of Primary Respondents<\/p>\n

3.6. Forecasting Techniques<\/p>\n

3.7. Research Methodology For Market Size Estimation<\/p>\n

3.8. Bottom-Up Approach<\/p>\n

3.9. Top-Down Approach<\/p>\n

3.10. Data Triangulation<\/p>\n

3.11. Validation<\/p>\n

4. MARKET DYNAMICS
<\/strong><\/p>\n

4.1. Overview<\/p>\n

4.2. Drivers<\/p>\n

4.3. Restraints<\/p>\n

4.4. Opportunities<\/p>\n

5. MARKET FACTOR ANALYSIS<\/strong><\/p>\n

…TOC Continued<\/strong><\/p>\n

LIST OF TABLES<\/strong><\/p>\n

TABLE 1 GLOBAL MENINGOCOCCAL VACCINES MARKET SYNOPSIS, 2019–2025<\/p>\n

TABLE 2 GLOBAL MENINGOCOCCAL VACCINES MARKET ESTIMATES & FORECAST, 2019–2025 (USD MILLION)<\/p>\n

TABLE 3 GLOBAL MENINGOCOCCAL VACCINES MARKET, BY TREATMENT TYPE, 2019–2025 (USD MILLION)<\/p>\n

TABLE 4 GLOBAL MENINGOCOCCAL VACCINES MARKET, BY END USER, 2019–2025 (USD MILLION)<\/p>\n

TABLE 5 GLOBAL MENINGOCOCCAL VACCINES MARKET, BY REGION, 2019–2025 (USD MILLION)<\/p>\n

TABLE 6 NORTH AMERICA MENINGOCOCCAL VACCINES MARKET, BY TREATMENT TYPE, 2019–2025 (USD MILLION)<\/p>\n

…Continued<\/strong><\/p>\n

LIST OF FIGURES<\/p>\n

FIGURE 1 RESEARCH PROCESS<\/p>\n

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL MENINGOCOCCAL VACCINES MARKET<\/p>\n

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL MENINGOCOCCAL VACCINES MARKET<\/p>\n

FIGURE 4 GLOBAL MENINGOCOCCAL VACCINES MARKET SHARE, BY TREATMENT TYPE, 2018 (%)<\/p>\n

FIGURE 5 GLOBAL MENINGOCOCCAL VACCINES MARKET SHARE, BY END USER, 2018 (%)<\/p>\n

FIGURE 6 GLOBAL MENINGOCOCCAL VACCINES MARKET SHARE, BY REGION, 2018 (%)<\/p>\n

…Continued<\/strong><\/p>\n

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https:\/\/www.marketresearchfuture.com\/reports\/meningococcal-vaccines-market-8622<\/a><\/strong> <\/p>\n

About Market Research Future:<\/strong><\/p>\n

At Market Research Future (MRFR)<\/strong>, we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.<\/p>\n

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.<\/p>\n

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.<\/p>\n

NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.<\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Market Research Future<\/a>
Contact Person:<\/strong> Abhishek Sawant
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9312
Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.marketresearchfuture.com\/reports\/meningococcal-vaccines-market-8622<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Meningococcal Vaccines Market Global Meningococcal Vaccines Market Research Report: Information, by Treatment (Meningococcal Conjugate Vaccine, Polysaccharide & Subcapsular Vaccine) and End User (Hospitals & Clinics, Research Laboratories and Academic Institutes) – Forecast till 2025 Meningococcal Vaccines Market Highlights According to Market … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[435,405,406,403,404],"tags":[],"class_list":["post-502156","post","type-post","status-publish","format-standard","hentry","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/502156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=502156"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/502156\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=502156"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=502156"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=502156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}